MKI67 and neoplasm: Consistently, the proportion of Ki67-positive cells in tumor sections was reduced significantly in the combination therapy groups for both spheroid lines, although no discernible changes were found in the histopathological features of PDSX tumors at the end of treatment for three weeks (p < 0.05; Figure 4A,B, right, Figure S3A,B).